Murali Gopalakrishnan Selected Research

Murali Gopalakrishnan Research Topics

Disease

10	Overactive Urinary Bladder (Overactive Bladder) 11/2007 - 10/2002
8	Alzheimer Disease (Alzheimer's Disease) 09/2010 - 06/2007
6	Schizophrenia (Dementia Praecox) 04/2012 - 07/2006
3	Neuroblastoma 12/2011 - 09/2010
3	Neuralgia (Stump Neuralgia) 10/2011 - 11/2006
3	Pain (Aches) 10/2011 - 11/2006
3	Neurodegenerative Diseases (Neurodegenerative Disease) 08/2009 - 01/2008
2	Fibrosis (Cirrhosis) 06/2018 - 12/2017
2	Inflammation (Inflammations) 10/2016 - 10/2011
2	Hyperalgesia 10/2011 - 11/2006
2	Urinary Bladder Neck Obstruction (Bladder Neck Obstruction) 01/2003 - 10/2002
1	Diabetic Nephropathies (Diabetic Nephropathy) 06/2018
1	Proteinuria 10/2016
1	Psychotic Disorders (Schizoaffective Disorder) 04/2012
1	Catalepsy 04/2012
1	Peritonitis 10/2011
1	Postoperative Pain 10/2011
1	Nausea 10/2011
1	Vomiting 10/2011
1	Tauopathies 04/2009
1	Mental Disorders (Mental Disorder) 09/2007
1	Dementia (Dementias) 09/2007
1	Central Nervous System Diseases (CNS Diseases) 07/2006
1	Urologic Diseases (Urinary Tract Disease) 10/2004
1	Lower Urinary Tract Symptoms 09/2004
1	Hypotension (Low Blood Pressure) 08/2004
1	Seizures (Absence Seizure) 01/2004
1	Hypothermia 01/2004
1	Cognitive Dysfunction 01/2004
1	Ataxia (Dyssynergia) 01/2004
1	Prostatic Neoplasms (Prostate Cancer) 06/2003

Drug/Important Bio-Agent (IBA)

9	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 04/2012 - 01/2004
6	Adenosine Triphosphate (ATP)IBA 02/2006 - 10/2002
4	alpha7 Nicotinic Acetylcholine ReceptorIBA 09/2010 - 09/2007
3	KATP ChannelsIBA 11/2007 - 01/2004
2	5-(2-azetidinylmethoxy)-2-chloropyridineIBA 10/2011 - 10/2011
2	Analgesics (Analgesic Drugs)IBA 10/2011 - 11/2006
2	5- (6- (1- azabicyclo(2,2,2)oct- 3- yloxy)pyridazin- 3- yl)- 1H- indoleIBA 09/2010 - 09/2010
2	Cholinergic ReceptorsIBA 08/2009 - 07/2009
2	Amyloid beta-PeptidesIBA 08/2008 - 06/2007
2	LigandsIBA 08/2008 - 11/2006
2	Peptides (Polypeptides)IBA 08/2008 - 06/2007
2	dicyandiamido (cyanoguanidine)IBA 11/2007 - 01/2004
2	9- (3- bromo- 4- fluorophenyl)- 2,3,5,6,7,9- hexahydrothieno(3,2- b)quinolin- 8(4H)- one 1,1-dioxideIBA 10/2002 - 10/2002
1	Tissue Inhibitor of Metalloproteinase-1IBA 06/2018
1	Losartan (Cozaar)FDA LinkGeneric 06/2018
1	Angiotensin IIIBA 06/2018
1	Biomarkers (Surrogate Marker)IBA 06/2018
1	Extracellular Matrix ProteinsIBA 12/2017
1	beta-apocarotenoid-14',13'-dioxygenase (ADO)IBA 10/2016
1	Adenosine (Adenocard)FDA LinkGeneric 10/2016
1	Purine NucleosidesIBA 10/2016
1	Antipsychotic Agents (Antipsychotics)IBA 04/2012
1	1- (5- chloro- 2,4- dimethoxyphenyl)- 3- (5- methylisoxazol- 3- yl)ureaIBA 12/2011
1	CalciumIBA 12/2011
1	CytokinesIBA 10/2011
1	Acetylcholine (Acetylcholine Chloride)FDA Link 10/2011
1	5- (6- (5- methylhexahydropyrrolo(3,4- c)pyrrol- 2(1H)- yl)pyridazin- 3- yl)- 1H- indoleIBA 10/2011
1	ZymosanIBA 10/2011
1	CarrageenanIBA 10/2011
1	3- (3- (pyridine- 3- yl)- 1,2,4- oxadiazol- 5- yl)benzonitrileIBA 10/2011
1	Acetates (Acetic Acid Esters)FDA Link 10/2011
1	Ligand-Gated Ion ChannelsIBA 08/2009
1	Glycogen Synthase Kinase 3 betaIBA 04/2009
1	GTP-Binding Proteins (G-Protein)IBA 01/2009
1	CannabinoidsIBA 01/2009
1	amyloid beta-protein (1-42)IBA 08/2008
1	2,2- dimethyl- 5- (6- phenylpyridazin- 3- yl)- 5- aza- 2- azoniabicyclo(2.2.1)heptaneIBA 01/2008
1	Amyloid (Amyloid Fibrils)IBA 06/2007
1	Proteins (Proteins, Gene)FDA Link 06/2007
1	Pregabalin (Lyrica)FDA Link 11/2006
1	Calcium Channels (Calcium Channel)IBA 11/2006
1	Gabapentin (Neurontin)FDA LinkGeneric 11/2006
1	HeptanesIBA 11/2006
1	Carboxylic AcidsIBA 11/2006
1	2-phenylglycineIBA 11/2006
1	Nicotine FDA Link 07/2006
1	Potassium Channels (Potassium Channel)IBA 10/2004
1	A-151892IBA 09/2004
1	pozaniclineIBA 01/2004
1	1-ethyl-2-benzimidazolinoneIBA 06/2003
1	RubidiumIBA 06/2003
1	Riluzole FDA LinkGeneric 06/2003
1	Tolterodine Tartrate (Detrol)FDA Link 01/2003
1	PotassiumIBA 10/2002
1	1,4-dihydropyridine (dihydropyridine)IBA 10/2002

Therapy/Procedure

2	Oral Administration 10/2016 - 10/2011
2	Therapeutics 04/2012 - 01/2003
1	Ligation 11/2006